Steroids

Volume 177, January 2022, 108948
Steroids

Practical and scalable synthesis of beclomethasone dipropionate

https://doi.org/10.1016/j.steroids.2021.108948Get rights and content

Highlights

  • Practical and scalable approach to synthesize beclomethasone dipropionate.
  • Readily available and cost-effective intermediate DB-11 as the starting material.
  • Optimized consistent conversion of DB-11 to beclomethasone with high purity.
  • A one-pot conversion of beclomethasone to beclomethasone dipropionate.

Abstract

Beclomethasone dipropionate (1) is a synthetic corticosteroid with anti-inflammatory, antipruritic, and anti-allergy properties. It is widely used to treat asthma, allergic rhinitis, and dermatoses. However, existing synthetic routes to this active pharmaceutical ingredient (API) contain steps resulting in low and/or inconsistent yields, and use obsolete reagents. Such inconsistencies coupled with a lack of reliable experimental data makes laboratory-scale and large-scale synthesis of this API difficult and time-consuming. In this paper, we report a practical and scalable approach to synthesize 1 from the readily available steroidal intermediate, 16β-methyl epoxide (3, DB-11). A gram-scale to kilogram-scale synthesis of 1 was achieved with 82% yield, using a cost-effective and scalable methodology. Selective propionylation of the hydroxyl groups at C17 and C21 demonstrate the fact that this approach can be conveniently implemented in fine chemical industries.

Introduction

Notably, 1 (Fig. 1) is an important active ingredient in the pharmaceutical industry as an anti-inflammatory corticosteroid administered for the treatment of various respiratory infections, diseases, and other allergic reactions, which elicit an inflammatory response in the human body [1], [2], [3], [4], [5]. The ability of 1 to undergo multiple formulations, such as nasal sprays, aerosols, dry powder inhalers, and ointments means that it can deliver a powerful local anti-inflammatory effect [6], [7], [8]. The most significant step in the synthesis of 1 is the selective propionylation of the hydroxyl groups at C17 and C21. These dipropionate ester groups of 1 contribute to increasing the lipophilicity of the drug and, thus, enhance the topical anti-inflammatory effect and offer the advantage of minimal systemic activity [9].
Therefore, installing the two propionate groups selectively at C17 and C21 is critical for its biological performance. Most of the earlier studies regarding the syntheses of 1 have been attempted without the protection of C11- hydroxyls [10], [11]. This approach resulted in getting poor yields of 1 and inseparable mixtures of C21-propionylated, C21, C11-dipropionylated, and C11-C17-C21-tripropionylated by-products [12], [13]. Therefore, various protecting groups (trihaloacetate, trimethylsilyl ether, tetrahydropyran ether, and nitrate ester) have been employed to protect C11-hydroxyl have been reported [14], [15], [16], [17], [18]. However, these have suffered from the selectivity of the protection-deprotection sequence, low yielding, and lack of applicability in scale-ups due to toxic reagents. It has also been reported that propionylation of the tertiary C17-hydroxyl group is tedious and requires temperatures ranging from 70 ˚C to 100 ˚C, which can cause degradation of the molecule resulting in low yields [19], [20]. Many other reported methods are also associated with unreacted starting materials, lack of selectivity, and the use of discontinued reagents, which makes large scale manufacturing extremely difficult. This limits the scalability of 1 [12], [21]. Moreover, our attempts to make 1 using most of the above approaches led to low and inconsistent yields along with large amounts of unusable by-products.
Only a few API manufactures of 1 in the world are accredited by good manufacturing practice (GMP). This may be because of the baffling synthetic approaches reported on 1. Furthermore, manufacturers of 1 do not reveal the synthetic know-how of their experimental procedures and hold them as trade secrets. To date, a refined and optimized methodology that is practical, scalable, and also provides comprehensive analytical data has not been reported. The wide commercial use of 1 and our long-standing interest in developing improved methodologies for the synthesis of APIs prompted us to develop a practical and scalable procedure for the asymmetric synthesis of 1. Each reaction has been carefully studied and optimized using mild and readily available reagents to obtain the highest yield. Analytical data of all intermediates have been reported to help an environment-friendly industrial scale-up process of 1.
Steroidal advance intermediate 3 (Fig. 1) was selected as the starting material to synthesize 1 due to its low cost and wide availability. The first step was the regioselective opening of C9-C11 epoxide to obtain 2. We investigated the previously reported procedures using 12 M concentrated hydrochloric acid (HCl), which produced C16-C17 -unsaturated 4 as the major product instead of product 2 (Scheme 1) [22]. Moreover, the reaction mixture progressively turned pink indicating the formation of the eliminated by-products 4 and 5. This was confirmed by LCMS and observed even at a 1 g scale, which resulted in low and inconsistent yields.
To reduce the formation of the eliminated by-products 4 and 5, the reaction was monitored at short time intervals and optimized using dilute HCl (1–5 M) (Table 1). Initially, when 1 M and 2 M HCL solutions were used, the reactions showed low conversion even after 300 min (Table 1, entries 1, 2, 3, and 4) This could be due to the low acidic concentrations, i.e., the SN1 mechanism to open up the epoxide was not feasible. When the concentration was increased to 3 M HCl solution, complete consumption of the starting material was observed rapidly (Table 1, entry 5). However, the yield was not optimal due to the formation of the mixture of eliminated products. Prolonging the reaction only produced more eliminated products, which resulted in a low isolated yield of 2 (Table 1, entry 6). Therefore, we decided to cool the reaction and introduce the HCl and then let the mixture return to room temperature (Table 1, entry 7). This resulted in the best yields and time profiles for the conversion of 3 to 2. Further, an increase in the concentration of HCl made more of 4 and 5, which resulted in low yields (Table 1, entries 8 and 9).
Typically, when the reactions in Table 1 was completed, the addition of the sodium bicarbonate (NaHCO3) solution directly to the reaction mixture made 2 precipitate from the reaction mixture. Filtering of the solid was followed by washing it with deionized water, which was followed by washing by a cold solvent yielded a white precipitate of 2 in high purity. However, the filtrate consisted of significant amounts of 2 resulting in the overall reaction yield being erroneous. Due to the poor solubility of 2, chromatography was not an option and further optimization was needed to improve the yield of this reaction. In practical considerations, chloroform should be avoided in scale-up reactions due to its high cost, low availability, and the safety and environmental concerns pertaining to it [23]. Therefore, screening for a solvent was explored. Thus, we confined our investigations only to certain criteria in choosing a new solvent including the following: (i) the conversion to 2 should be as high as observed in chloroform (Table 1, entry 7), (ii) it should produce minimum amounts of byproducts 4 and 5, (iii) it must readily precipitate 2 by adding NaHCO3 solution directly to the reaction mixture. To find out the suitable solvent that provides a conversion as high as that observed in chloroform, some commonly available solvents, such as toluene, dichloromethane (DCM), THF, ethyl acetate, and diethyl ether, were explored. To our delight, it was observed that when switching the solvent from chloroform to DCM (Table 1, entry 12) the by-product formation was minimized and the precipitate formation of 2 was elevated by the addition of NaHCO3 solution directly to the reaction mixture. The resulting precipitate of 2 was pure enough to be used in the next reactions without any further purification. This optimized procedure was successful to produce high yields (92–97 %) and was consistent up to 1 kg scale-up reactions. This outcome is very important from the point of view of industrial-scale production of 2 as it eliminates the practical difficulties of using chloroform and the cost of additional purification steps from the total production costs. To date, this is the highest yielding process reported to obtain 2.
With high purity 2 in hand, next, we attempted the propionylation of C21 and C17 hydroxyl groups (Scheme 2). According to the most recent method reported, by simply adding propionyl chloride or propionyl anhydride to 2 can only propionylate C21 and C11 hydroxyl groups and not C17 hydroxyl group [12]. Even under harsh conditions, the C17 hydroxyl group did not propionylate and the reaction halted at C21, C11 dipropionate 7 (Scheme 2).
It has been reported that Trifluoroacetic acid and p-toulenesulfonic acid (pTSA) can be used to propionate tertiary alcohols in steroidal systems [19]. Therefore, we investigated whether these acid pair conditions can propionate the C17-hydroxyl of 7. Compound 7 was subjected to the acid pair conditions which gave C11, C17, and C21 tripropionated product 6 in moderate yield (Scheme 3). However, selective hydrolysis of the C11 ester to yield 1 was impossible since C17 and C21 esters was also hydrolyzing (Scheme 3).
Since 3 has the C11-hydroxyl already protected with the epoxide, we envisioned that the propionylation of this would lead to 1 without going through the hydrolysis of the tripropionated by-product 6. Therefore, we first reacted 3 with propionic anhydride to get the C21-hydroxyl group propionylated to yield 8 (Scheme 4). Thereafter, 8 was treated with acid pair conditions to yield 9. However, this reaction produced many by-products with only trace amounts of the desired product 8. This could be due to the strongly acidic conditions forcing the epoxide to open which leads to these by-products. As our goal was to develop a short, simple, and robust method to synthesize 1 without going through a protection-deprotection sequence, we concluded that moving forward with this approach was not fruitful.
Given that all the previous attempts failed to selectively dipropionate C17 and C21 hydroxyl groups, we decided to use the 1,3 dihydroxyl uniqueness of substrate 2 to get the desired product, i.e., product 1. Therefore, we treated 2 with triethyl orthopropionate (TEOP) to obtain 10 which was converted in situ via 6-exo-tet favorable cyclization to 10 (Scheme 5) [24], [25], [26]. Notably, 10 was isolated via crystallization and subjected to 3 M HCl conditions for 3 h. To our delight, this substate-controlled reaction to obtain C17 mono propionylated product 11 produced a quantitative yield (Scheme 5).
A detailed reaction mechanism of the cyclocondensation of 2 by TEOP followed by the hydrolysis to yield 11 has been outlined in Scheme 6. We believed that the transformation from 2 to 11 could be due to the water molecule attacking the C21 carbon of the oxocarbenium ion (13) (Scheme 6).
Inspired by the proposed mechanism (Scheme 6), we attempted to develop a one-pot reaction to convert 2 directly to 11 by skipping the isolation of 10. Therefore, 2 was treated with TEOP and this reaction was closely monitored via TLC. After the reaction was completed, 6 M HCl was directly added to the reaction, which turned the solution to light yellow color (Fig. 2). After completion of the reaction, the reaction mixture was neutralized with NaHCO3 solution and worked up to get 88% yield of compound 11 (Scheme 5). The purity of 11 after the workup was high enough to proceed to the next step without further purifying it. This protocol produced 11 in high yield and was consistent with 1 kg scale-up reactions (Fig. 2). With 11 in hand, next, we attempted to selectively propionylate the C21-hydroxyl group under mild conditions. We treated 11 in less reactive propionic anhydride conditions to get the much-anticipated 1, and its yield was 96 %. In all these transformations, we did not observe any chiral erosion of the intermediates.
The overall yield of 1 starting with the yield from 3 was 82 %. To our knowledge, this is the highest yield reported for the synthesis of 1. We believe that this procedure will provide a more practical alternative to the existing methods to synthesize 1 in kilo-scale as all the reactions were optimized and tested from 1 g to 1 kg scale to repeatedly give consistent yields. For the fine-chemical industries, the development of straightforward methods to prepare highly valuable synthetic intermediates from commercial and easily synthesizable chemicals is of enormous interest. Our improved methodology and detailed experimental data would, no doubt, be beneficial to the pharmaceutical and other fine chemical industries.

Access through your organization

Check access to the full text by signing in through your organization.

Access through your organization

Section snippets

Experimental section

All the solvents and chemicals were used as purchased from Sigma without any further purification. The progress of all reactions was monitored on Merck’s pre-coated silica gel plates (with fluorescence indicator UV 254) using ethyl acetate/n-hexane as the solvent system. The purification of the final compounds was done mostly by recrystallization using specific solvents/solvent systems mentioned that have been referred to in each experiment. Other than this, column chromatography was performed

Acknowledgements

The authors would like to acknowledge the support received from Colin Peiris toward NMR, LC-MS, chiral HPLC, and optical rotation analysis. The authors would also like to gratefully acknowledge the technical and process chemistry support offered by Sunanda Gunasekara, Eshan Malintha and Dr. Nuwan de Silva. The authors are also grateful to Randika Shamal and the financial department of the Sri Lanka Institute of Nanotechnology (SLINTEC) for their support.

References (26)

  • M.A. Avery et al.

    Synthesis and antiinflammatory activity of novel 12. beta.-substituted analogs of betamethasone

    Journal of Medicinal Chemistry.

    (1990)
  • 韩昆颖, 孙亮, Synthetic method of beclomethasone dipropionate organic-free solvent, CN104558083A, 2015....
  • Y. Zhang et al.

    Synthesis of Betamethasone Dipropionate

    Chinese Journal of Modern Applied Pharmacy.

    (2011)
  • View full text